Therapy for chikungunya arthritis: a study of 133 Brazilian patients
Chikungunya fever is a global vector-borne viral disease. Patients with acute chikungunya are usually treated symptomatically. The arthritic phase may be self-limiting. However, many patients develop extremely disabling arthritis that does not improve after months. The aim of this study was to descr...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Society of Tropical Medicine and Hygiene
2023
|
| _version_ | 1811140363582177280 |
|---|---|
| author | Amaral, JK Bingham, CO Taylor, PC Vilá, LM Weinblatt, ME Schoen, RT |
| author_facet | Amaral, JK Bingham, CO Taylor, PC Vilá, LM Weinblatt, ME Schoen, RT |
| author_sort | Amaral, JK |
| collection | OXFORD |
| description | Chikungunya fever is a global vector-borne viral disease. Patients with acute chikungunya are usually treated symptomatically. The arthritic phase may be self-limiting. However, many patients develop extremely disabling arthritis that does not improve after months. The aim of this study was to describe the treatment of chikungunya arthritis (CHIKA) patients. A medical records review was conducted in 133 CHIKA patients seen at a rheumatology practice. Patients were diagnosed by clinical criteria and confirmed by the presence of anti-chikungunya IgM. Patients were treated with methotrexate (20 mg/week) and/or leflunomide (20 mg/day) and dexamethasone (0-4 mg/day) for 4 weeks. At baseline visit and 4 weeks after treatment, Disease Activity Score 28 (DAS28) and pain (using a visual analog scale) were ascertained. Five months after the end of treatment, patients were contacted to assess pain, tender joint count, and swollen joint count. The mean age of patients was 58.6 ± 13.7 years, and 119 (85%) were female. After 4 weeks of treatment, mean (SD) DAS28-erythrocyte sedimentation rate (6.0 [1.2] versus 2.7 [1.0], P < 0.001) and pain (81.8 [19.2] to 13.3 [22.9], P < 0.001) scores significantly decreased. A total of 123 patients were contacted 5 months after the end of treatment. Pain score, tender joint count, and swollen joint count significantly declined after 4 weeks of treatment, and the response was sustained for 5 months. In this group of patients with CHIKA, 4-week treatment induced a rapid clinical improvement that was maintained 5 months after the end of therapy; however, the contribution of treatment to these outcomes is uncertain. |
| first_indexed | 2024-03-07T08:27:53Z |
| format | Journal article |
| id | oxford-uuid:99e677a4-7729-4a74-9acd-98defaf73846 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:20:48Z |
| publishDate | 2023 |
| publisher | American Society of Tropical Medicine and Hygiene |
| record_format | dspace |
| spelling | oxford-uuid:99e677a4-7729-4a74-9acd-98defaf738462024-08-07T10:42:47ZTherapy for chikungunya arthritis: a study of 133 Brazilian patientsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:99e677a4-7729-4a74-9acd-98defaf73846EnglishSymplectic ElementsAmerican Society of Tropical Medicine and Hygiene2023Amaral, JKBingham, COTaylor, PCVilá, LMWeinblatt, MESchoen, RTChikungunya fever is a global vector-borne viral disease. Patients with acute chikungunya are usually treated symptomatically. The arthritic phase may be self-limiting. However, many patients develop extremely disabling arthritis that does not improve after months. The aim of this study was to describe the treatment of chikungunya arthritis (CHIKA) patients. A medical records review was conducted in 133 CHIKA patients seen at a rheumatology practice. Patients were diagnosed by clinical criteria and confirmed by the presence of anti-chikungunya IgM. Patients were treated with methotrexate (20 mg/week) and/or leflunomide (20 mg/day) and dexamethasone (0-4 mg/day) for 4 weeks. At baseline visit and 4 weeks after treatment, Disease Activity Score 28 (DAS28) and pain (using a visual analog scale) were ascertained. Five months after the end of treatment, patients were contacted to assess pain, tender joint count, and swollen joint count. The mean age of patients was 58.6 ± 13.7 years, and 119 (85%) were female. After 4 weeks of treatment, mean (SD) DAS28-erythrocyte sedimentation rate (6.0 [1.2] versus 2.7 [1.0], P < 0.001) and pain (81.8 [19.2] to 13.3 [22.9], P < 0.001) scores significantly decreased. A total of 123 patients were contacted 5 months after the end of treatment. Pain score, tender joint count, and swollen joint count significantly declined after 4 weeks of treatment, and the response was sustained for 5 months. In this group of patients with CHIKA, 4-week treatment induced a rapid clinical improvement that was maintained 5 months after the end of therapy; however, the contribution of treatment to these outcomes is uncertain. |
| spellingShingle | Amaral, JK Bingham, CO Taylor, PC Vilá, LM Weinblatt, ME Schoen, RT Therapy for chikungunya arthritis: a study of 133 Brazilian patients |
| title | Therapy for chikungunya arthritis: a study of 133 Brazilian patients |
| title_full | Therapy for chikungunya arthritis: a study of 133 Brazilian patients |
| title_fullStr | Therapy for chikungunya arthritis: a study of 133 Brazilian patients |
| title_full_unstemmed | Therapy for chikungunya arthritis: a study of 133 Brazilian patients |
| title_short | Therapy for chikungunya arthritis: a study of 133 Brazilian patients |
| title_sort | therapy for chikungunya arthritis a study of 133 brazilian patients |
| work_keys_str_mv | AT amaraljk therapyforchikungunyaarthritisastudyof133brazilianpatients AT binghamco therapyforchikungunyaarthritisastudyof133brazilianpatients AT taylorpc therapyforchikungunyaarthritisastudyof133brazilianpatients AT vilalm therapyforchikungunyaarthritisastudyof133brazilianpatients AT weinblattme therapyforchikungunyaarthritisastudyof133brazilianpatients AT schoenrt therapyforchikungunyaarthritisastudyof133brazilianpatients |